Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · F-4

Pharma Two B Ltd.

SEC Filing

Filed Sep 4, 2024Accepted Sep 4, 2024, 5:16 AM EDTCIK 2034526Accession 0001213900-24-075342
Share

Recent company filings

  1. 15-15D filingDec 12, 2024
  2. RW filingDec 12, 2024
  3. 424B3 filingDec 12, 2024
  4. 6-K filingDec 12, 2024
  5. EFFECT filingNov 8, 2024

As-filed source

Primary evidence